Aggregation-dependent interaction of the Alzheimer's β-amyloid and microglia

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 4, 2001, Pages 313-316

  Muehlhauser, Frank ^a   Liebl, Ulrike ^a   Kuehl, Sandra ^a   Walter, Silke ^a   Bertsch, Thomas ^a   Faßbender, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Amyloid peptide; Brain; Microdialysis, in vivo; Nitric oxide; Nitric oxide synthase, inducible

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; NITRIC OXIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; IN VIVO STUDY; MALE; METABOLITE; MICRODIALYSIS; MICROGLIA; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; INTERFERON TYPE II; KINETICS; MICE; MICE, INBRED BALB C; MICROGLIA; MICROSCOPY, ELECTRON; NEUROGLIA; NITRIC OXIDE; PROTEIN BINDING; TIME FACTORS;

ANIMALIA;

EID: 0035040988     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.048     Document Type: Article

References (25)

1. Beyreuther K, Multhaup G, Monning U, Sandbrink R, Beher D, Hesse L, et al. Regulation of APP expression biogenesis and metabolism by extracellular matrix and cytokines. Ann NY Acad Sci 1996; 777:74-6.
2. Xia MQ, Qin SX, Wu LJ, Mackay CR, Hyman BT. Immunohisto-chemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am J Pathol 1998; 153:31-7.
3. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86:7611-5.
4. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F b-amyloid precursor protein. Nature 1995; 373:523-7.
5. London JA, Biegel D, Pachter JS. Neurocytopathic effects of b-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease. Proc Natl Acad Sci USA 1996; 93:4147-52.
6. Klegeris A, Walker DG, McGeer PL. Activation of macrophages by Alzheimer β amyloid peptide. Biochem Biophys Res Commun 1994; 199:984-91.
7. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 1996; 382:716-9.
8. Van SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996; 382:685-91.
9. Della Bianca V, Dusi S Bianchini, E Dal Pra I, Rossi F. Beta-amyloid activates the O2 forming NADPH oxidase in microglia monocytes and neutrophils A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 1999; 274:15493-9.
10. Goodwin JL Uemura E, Cunnick JE. Microglial release of nitric oxide by synergistic action of beta amyloid and IFN-gamma. Brain Res 1995; 692:207-14.
11. Meda L, Cassatella MA, Szendrei GI, Otvos L, Jr Baron P, Villalba M, et al. Activation of microglial cells by bamyloid protein and interferon-γ. Nature 1995; 374:647-9.
12. McGeer PL, Schulzer M, McGeer E. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996; 47:425-32.
13. Harper JD, Lansbury PT. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997; 66:385-407.
14. Burdick D, Soreghan B, Kwon B, Kosmoski J, Knauer M, Henschen A, Yates J. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 1992; 267:546-54.
15. Suzumura A, Mezitis SGE, Gonatas NK, Silberberg DH. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J Neuroimmunol 1987; 15:263-78.
16. Paxinos G, Watson C. The rat brain in stereotactic coordinates. Sydney. Academic Press, 1982.
17. Knauber J, Kischka U, Roth M, Schmidt WJ, Hennerici M, Fassbender K. Modulation of striatal acetylcholine concentrations by NMDA and the competitive NMDA receptor-antagonist AP-5: an in vivo microdialysis study. J Neural Transm 1999; 106:35-45.
18. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-12.
19. Ding M, St Pierre BA, Parkinson JF, Medberry P, Wong JL, Rogers NE, et al. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. A kinetic analysis. J Biol Chem 1997; 272:11327-35.
20. Netland EE, Newton JL, Majocha RE, Tate BA. Indomethacin reverses the microglial response to amyloid beta-protein. Neurobiol Aging 1998; 19:201-4.
21. Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, et al. Fibrillar β-amyloid induces microglial phagocytosis expression of inducible nitric oxide synthase and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 1998; 18:2161-73.
22. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78:931-6.
23. Yun H-Y, Dawson VL, Dawson TM. Neurobiology of nitric oxide. Crit Rev Neurobiol 1996; 10:291-316.
24. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain damage. Trends Neurosci 1997; 20:132-8.
25. O'Mahony D, Kendall MJ. Nitric oxide in acute ischaemic stroke: a target for neuroprotection. J Neurol Neurosurg Psychiatry 1999:671-3.